Select Medical Holdings (SEM) Receivables (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Receivables data on file, last reported at $949.5 million in Q1 2026.

• Receivables for Q1 2026 came in at $949.5 million, up 4.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $949.5 million (up 4.55% YoY), and the FY2025 annual result was $864.2 million, up 5.21% from the prior year.
• Receivables advanced to $949.5 million in Q1 2026 per SEM's latest filing, from $864.2 million in the prior quarter.
• Over five years, Receivables peaked at $1.1 billion in Q1 2024 and troughed at $724.1 million in Q4 2023.
• A 5-year average of $936.0 million and a median of $941.4 million in 2022 frame the typical range for Receivables.
• The sharpest annual moves came in 2023 and 2024: Receivables declined 24.38% in 2023, then increased 13.79% in 2024.
• A 5-year view of Receivables shows it stood at $957.6 million in 2022, then decreased by 24.38% to $724.1 million in 2023, then rose by 13.43% to $821.4 million in 2024, then gained by 5.21% to $864.2 million in 2025, then advanced by 9.87% to $949.5 million in 2026.
• Business Quant data shows SEM's Receivables at $949.5 million in Q1 2026, $864.2 million in Q4 2025, and $825.8 million in Q3 2025.